Alpheus Medical

Alpheus Medical is a clinical-stage oncology company developing sonodynamic therapy (SDT) for solid tumors. Their platform combines low-intensity diffuse ultrasound (LIDU™) with oral 5-aminolevulinic acid (5-ALA) to selectively target and destroy cancer cells while sparing healthy tissue. This novel approach is designed to be non-invasive and suitable for outpatient settings.

Funding Round: Series B

Funding Amount: $52M

Date: 15-May-2025

Investors: HealthQuest Capital, Samsara BioCapital, OrbiMed, Action Potential Venture Capital, BrightEdge, Brain Tumor Investment Fund, Sontag Innovation Fund

Markets: Healthtech, Oncology

HQ: Chanhassen, Minnesota, United States

Founded: 2014

Website: http://www.alpheusmedical.com/

LinkedIn: https://www.linkedin.com/company/alpheus-medical-inc

Twitter: https://twitter.com/alpheusmedical

Instagram:

Facebook: https://www.facebook.com/100083582269193

Crunchbase: https://www.crunchbase.com/organization/alpheus-medical

Pitchbook: https://pitchbook.com/profiles/company/186247-18